Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD
出版年份 2023 全文链接
标题
Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD
作者
关键词
-
出版物
Protein & Cell
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2023-07-20
DOI
10.1093/procel/pwad040
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
- (2023) Can Yue et al. LANCET INFECTIOUS DISEASES
- Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
- (2023) Jessica Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
- (2023) Ryuta Uraki et al. LANCET INFECTIOUS DISEASES
- Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
- (2023) Delphine Planas et al. Nature Communications
- Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
- (2023) Panke Qu et al. Cell Reports
- Human Antibodies for Viral Infections
- (2022) James E. Crowe Annual Review of Immunology
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- An engineered bispecific human monoclonal antibody against SARS-CoV-2
- (2022) Zhaohui Li et al. NATURE IMMUNOLOGY
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
- (2022) Shane Miersch et al. Cell Reports
- Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
- (2022) Siling Wang et al. Cell Reports
- An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern
- (2022) Wenjuan Du et al. Science Immunology
- Designing antibodies as therapeutics
- (2022) Paul J. Carter et al. CELL
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- The emergence of Omicron lineages BA.4 and BA.5, and the global spreading trend
- (2022) Perumal A. Desingu et al. JOURNAL OF MEDICAL VIROLOGY
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
- (2022) Qian Wang et al. NATURE
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
- (2022) Houriiyah Tegally et al. NATURE MEDICINE
- The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
- (2022) Hualong Xiong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A counterintuitive antibody cocktail disrupts coxsackievirus
- (2022) Seth J. Zost et al. Cell Host & Microbe
- Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail
- (2022) Qingbing Zheng et al. Cell Host & Microbe
- Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
- (2022) Qian Wang et al. Cell Host & Microbe
- Evasion of neutralising antibodies by omicron sublineage BA.2.75
- (2022) Daniel J Sheward et al. LANCET INFECTIOUS DISEASES
- Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
- (2022) Henning Gruell et al. LANCET INFECTIOUS DISEASES
- Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
- (2022) Zhiqiang Ku et al. Nature Communications
- Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
- (2022) Yingdan Wang et al. Cell Discovery
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
- (2022) Qian Wang et al. CELL
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
- (2022) Panke Qu et al. Cell Host & Microbe
- Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
- (2022) Théophile Cocherie et al. Microorganisms
- Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
- (2021) C. Garrett Rappazzo et al. SCIENCE
- Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
- (2021) Chao Zhang et al. Nature Communications
- The prevalence of antibodies to SARS-CoV-2 among blood donors in China
- (2021) Le Chang et al. Nature Communications
- The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
- (2021) Richard Copin et al. CELL
- Broad sarbecovirus neutralization by a human monoclonal antibody
- (2021) M. Alejandra Tortorici et al. NATURE
- SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
- (2021) Tyler N. Starr et al. NATURE
- Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
- (2021) Jinhui Dong et al. Nature Microbiology
- Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
- (2021) Vincent Dussupt et al. NATURE IMMUNOLOGY
- A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
- (2021) David R. Martinez et al. Science Translational Medicine
- Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
- (2021) Tingting Li et al. Nature Communications
- Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
- (2021) Tingting Li et al. Nature Communications
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- UCSF ChimeraX : Structure visualization for researchers, educators, and developers
- (2020) Eric F. Pettersen et al. PROTEIN SCIENCE
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
- (2020) M. Alejandra Tortorici et al. SCIENCE
- Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
- (2020) Hejun Liu et al. IMMUNITY
- A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
- (2020) Nicholas C. Wu et al. PLoS Pathogens
- MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
- (2017) Shawn Q Zheng et al. NATURE METHODS
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- UCSF ChimeraX: Meeting modern challenges in visualization and analysis
- (2017) Thomas D. Goddard et al. PROTEIN SCIENCE
- Gctf: Real-time CTF determination and correction
- (2016) Kai Zhang JOURNAL OF STRUCTURAL BIOLOGY
- Deciphering key features in protein structures with the new ENDscript server
- (2014) Xavier Robert et al. NUCLEIC ACIDS RESEARCH
- Quantifying the local resolution of cryo-EM density maps
- (2013) Alp Kucukelbir et al. NATURE METHODS
- Prevention of overfitting in cryo-EM structure determination
- (2012) Sjors H W Scheres et al. NATURE METHODS
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search